Evidence map›Paper›PMID 39157631›Full record

ArticleEJHaem2024

Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma.

Tomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, Daisuke Katoh, Daisuke Yamashita, Hironaga Satake, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Momoko Nishikori and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tomohiro YabushitaDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.ORCID https://orcid.org/0000-0003-1505-3650
Yoshimitsu ShimomuraDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.ORCID https://orcid.org/0000-0003-1018-9508
Hayato MaruokaDepartment of Clinical Laboratory Kobe City Medical Center General Hospital Kobe Japan.
Daisuke KatohDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.
Daisuke YamashitaDepartment of Pathology Kobe City Medical Center General Hospital Kobe Japan.
Hironaga SatakeDepartment of Medical Oncology Kobe City Medical Center General Hospital Kobe Japan.
Nobuhiro HiramotoDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.
Satoshi YoshiokaDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.
Noboru YonetaniDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.
Momoko NishikoriDepartment of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0003-4171-2162
Takeshi MorimotoClinical Research Center Kobe City Medical Center General Hospital Kobe Japan.
Yukihiro ImaiDepartment of Pathology Kobe City Medical Center General Hospital Kobe Japan.
Takayuki IshikawaDepartment of Hematology Kobe City Medical Center General Hospital Kobe Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic hypermutations (SHMs) in the variable region (V

Indexed as

BIOMED‐2 protocolcomplete IgH gene rearrangementdiffuse large B‐cell lymphomaFR3neoantigen

Identifiers

PMID39157631
PMCPMC11327714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.